52w high/low | ₹544.9 / ₹383.2 |
P/E ratio | 41.1 |
Dividend | 0.1 |
ROE | 17.39 |
ROCE | 23.81 |
Face value | 2 |
Book value | ₹112.56Cr |
Market capital | ₹6,473.23Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
The company was incorporated as Supriya Lifescience Limited on 26 March 2008 upon the conversion of M/s Supriya Chemicals,a partnership firm, into a public limited company. The company commenced operations on 01 April 2008. The company is engaged in manufacturing and export of active pharmaceutical ingredients(APIs). The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients,with a focus on research and development. As of 31 March 2021,the company have niche product offerings of 39 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic. The company have consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-55% and 65-70%, respectively,of the API exports from India, between Fiscal 2017 and 2020. The company is among the largest exporters of Salbutamol Sulphate from India in Fiscal 2020 in terms of volume. The company's products are approved by various international regulatory authorities such as USFDA, EUGMP, EDQM, SFDA NMPA, ANVISA, KFDA, PMDA, TGA and Taiwan FDA.